Knorex does not have a credible set of current analyst price targets. Because the company went public only in September 2025 via a $12 million initial public offering and has a market capitalization of roughly $4.4 million, major brokerage coverage is essentially absent. In place of an analyst-derived mean, the $0.20 objective used here reflects what is actually being discussed publicly: the only recent quantified price objective is an AI-generated target near $0.17 published by TipRanks in October 2026, while technical recovery benchmarks point to the stock's 50-day moving average near $0.27. Rounding these to a clean, realistic recovery level produces the $0.20 figure used throughout this article. This is a fallback target, not a Wall Street consensus, and it is presented for analytical context only. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
The latest verified closing price for KNRX is around $0.14, with shares trading as low as roughly $0.13 in early November 2026. Reaching $0.20 would require an upside of approximately 43%, a substantial move. The path would likely depend on a stabilization of the company's finances rather than a single catalyst. Knorex's most recent quarterly report, released October 28, 2026, showed an EPS (earnings per share) of -$0.09 on revenue of $1.34 million, continuing a pattern of losses. For fiscal 2025, revenue declined roughly 15% year over year to about $6.04 million while the net loss widened, leaving shareholders' equity negative. A recovery toward $0.20 would likely require evidence of renewed revenue growth, reduced cash burn, and resolution of its listing-compliance concerns.
Knorex's core asset is its flagship platform, Knorex XPO, a self-service, enterprise-grade cloud platform for cross-channel programmatic advertising across search, social, video, connected TV, and digital out-of-home media. The company has emphasized AI and machine-learning capabilities, and its 2024 revenue grew about 24% to $10.8 million before contracting in 2025. A return to growth, successful customer wins, or a reduction in operating losses could improve investor sentiment. Given the stock's tiny float and market capitalization, even modest positive news has historically produced outsized percentage moves, which cuts both ways but means a recovery toward $0.20 is not out of reach if fundamentals stabilize.
The obstacles are significant. Knorex has reported a deeply negative net margin, negative shareholders' equity, and worsening free cash flow. Its financial statements for fiscal 2025 included going-concern language, and the company has received a non-compliance notice from NYSE American over listing standards, along with reporting around a delayed annual filing. These issues raise solvency and delisting risk that could further erode investor confidence. Competition in programmatic advertising is intense, and the company's small scale limits its ability to absorb continued losses. None of these factors guarantees failure, but they materially raise the bar for any sustained recovery toward $0.20.
From a technical standpoint, KNRX is deeply broken. The stock trades below both its 50-day moving average, near $0.27, and its 200-day moving average, near $0.72, and sits roughly 96% below its all-time high of $4.00. The $0.20 objective represents an intermediate level that would still leave the stock below its major moving averages, meaning any move toward it would likely be a technical rebound within a broader downtrend rather than a confirmed trend reversal. Meaningful overhead resistance sits at the 50-day moving average near $0.27, while the recent lows around $0.13–$0.14 act as near-term support.
Because there is no analyst consensus, there is no formal 12-month price-target horizon attached to KNRX. Investors should instead watch the next earnings report, expected around November 20, 2026, for any sign of revenue stabilization or cost discipline. Equally important are updates on the NYSE American non-compliance matter, any resolution of the delayed annual filing, cash balances and financing activity, and any new customer or platform announcements. Given the company's financial position, capital-raising news and going-concern disclosures will likely matter as much as operating results.
Can Knorex reach $0.20? The target represents a fallback recovery objective of roughly 43% above the latest price near $0.14, drawn from the only recent quantified price figure (an AI-generated $0.17) and technical benchmarks near $0.27, rather than from analyst coverage. The strongest support would come from stabilized revenue and reduced losses, while the principal obstacles are persistent losses, negative equity, going-concern language, and listing-compliance risk. A move toward $0.20 is possible, especially given the stock's small float, but it would likely be a rebound within a downtrend unless the company's fundamentals meaningfully improve. Investors should watch earnings, compliance updates, and cash-flow trends before drawing conclusions. From what I see, this remains a high-risk situation worth monitoring closely.
In my own research process, Tickeron’s AI Daily Buy/Sell Signals have been useful for tracking momentum in volatile names like this. The tool applies artificial intelligence to monitor thousands of stocks and ETFs, generating Buy, Sell, or Hold signals based on shifting market conditions and technical behavior. For thinly traded stocks, these insights can help identify changing trends more efficiently than manual tracking alone.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
The 10-day moving average for KNRX crossed bearishly below the 50-day moving average on October 08, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 4 of 4 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where KNRX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for KNRX entered a downward trend on November 06, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 6 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
The Moving Average Convergence Divergence (MACD) for KNRX just turned positive on October 26, 2026. Looking at past instances where KNRX's MACD turned positive, the stock continued to rise in 6 of 6 cases over the following month. The odds of a continued upward trend are 90%.
Following a +2.81% 3-day Advance, the price is estimated to grow further. Considering data from situations where KNRX advanced for three days, in 28 of 35 cases, the price rose further within the following month. The odds of a continued upward trend are 80%.
KNRX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron Valuation Rating of 39 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (-1.906). P/E Ratio (0.000) is within average values for comparable stocks, (9.554). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.824). Dividend Yield (0.000) settles around the average of (0.069) among similar stocks. P/S Ratio (1.470) is also within normal values, averaging (70.383).
The Tickeron Price Growth Rating for this company is 93 (best 1 - 100 worst), indicating slightly worse than average price growth. KNRX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. KNRX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry PackagedSoftware